Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Cannabis as Myeloma Therapy?
Cannabis as Myeloma Therapy?
Cannabis as myeloma therapy is still an open question according to the study linked below. Yes, cannabis can have an important role to play in the management of MM but it is still up to the MM patient to figure out what that role is.
The takeaways from the study as I see them are:
- 10,000 research papers focusing on cannabis and cancer-
- medicine is overwhelmingly in favor of “medical cannabis-“
- cannabis’s function for MM is for pain, nausea and appetite loss-
- cannabis being cytotoxic to MM is still an open question-
Using Medical Marijuana During Cancer Treatment
I am a long-term MM survivor. I put CBD oil (Charlotte’s Web) under my tongue just before bed each night to help me sleep. I’ve always taken a multi-pronged approach to managing both my MM as well as my short, long-term and late stage side effects.
I’m old enough to remember my parents thinking that marijuana was a “gateway drug” and its use being negative in every way. As with all evidence-based non-conventional therapies-
- dosing
- administration
- sourcing, etc.
all must be still be determined before the average MM patients will incorporate medical cannabis into their lives. But the study below and the short video above are an important step forward.
Email me at David.PeopleBeatingCancer@gmail.com with questions about managing your multiple myeloma with both conventional and non-conventional therapies.
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Meta-analysis of medical cannabis outcomes and associations with cancer
Background: Growing bodies of evidence suggest that cannabis may play a significant role in both oncological palliative care and as a direct anticarcinogenic agent, but classification as a Schedule I substance has complicated research into its therapeutic potential, leaving the state of research scattered and heterogeneous. This meta-analysis was conducted to determine the scientific consensus on medical cannabis’ viability in cancer treatment.
Objective: The aim of this meta-analysis was to systematically assess the existing literature on medical cannabis, focusing on its therapeutic potential, safety profiles, and role in cancer treatment.
Methods: This study synthesized data from over 10,000 peer-reviewed research papers, encompassing 39,767 data points related to cannabis and various health outcomes. Using sentiment analysis, the study identified correlations between cannabis use and supported, not supported, and unclear sentiments across multiple categories, including cancer dynamics, health metrics, and cancer treatments. A sensitivity analysis was conducted to validate the reliability of the findings.
Results: The meta-analysis revealed a significant consensus supporting the use of medical cannabis in the categories of:
- health metrics,
- cancer treatments,
- and cancer dynamics.
The aggregated correlation strength of cannabis across all cancer topics indicates that support for medical cannabis is 31.38× stronger than opposition to it. The analysis highlighted the anti-inflammatory potential of cannabis, its use in managing cancer-related symptoms such as
- pain,
- nausea,
- and appetite loss,
and explored the consensus on its use as an anticarcinogenic agent.
Discussion: The findings indicate a strong and growing consensus within the scientific community regarding the therapeutic benefits of cannabis, particularly in the context of cancer. The consistent correlation strengths for cannabis as both a palliative adjunct and a potential anticarcinogenic agent redefine the consensus around cannabis as a medical intervention.
Conclusion: The consistency of positive sentiments across a wide range of studies suggests that cannabis should be re-evaluated within the medical community as a treatment option. The findings have implications for public health research, clinical practice, and discussions surrounding the legal status of medical cannabis. These results suggest a need for further research to explore the full therapeutic potential of cannabis and address knowledge gaps…
Cannabis as myeloma therapy Cannabis as myeloma therapy